Treatment of epilepsy to optimize bone health

Current Treatment Options in Neurology

Volumn 13, Issue 4, 2011, Pages 346-354

  Pack, Alison M ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CALCIUM; CARBAMAZEPINE; ETIRACETAM; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; PREGNANE X RECEPTOR; TOPIRAMATE; VALPROIC ACID; VITAMIN D; ZONISAMIDE;

ARTICLE; BONE CHARACTERISTICS AND FUNCTIONS; BONE DENSITY; BONE DISEASE; BONE HEALTH; BONE TURNOVER; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; EPILEPSY; HUMAN; KIDNEY TUBULE ACIDOSIS; LOW DRUG DOSE; MASS SCREENING; NONHUMAN; OSTEOLYSIS; RISK FACTOR; SEX DIFFERENCE; SIDE EFFECT; TREATMENT OUTCOME;

EID: 80051666841     PISSN: 10928480     EISSN: 15343138     Source Type: Journal    
DOI: 10.1007/s11940-011-0133-x     Document Type: Article

References (47)

1. A Pack 2008 Bone health in people with epilepsy: Is it impaired and what are the risk factors? Seizure 17 2 18 10.1016/j.seizure.2007.11.020
2. PC Souverein DJ Webb H Petri, et al. 2005 Incidence of fractures among epilepsy patients: a population-based retrospective cohort study in the General Practice Research Database Epilepsia 46 2 304 310 15679512 10.1111/j.0013-9580. 2005.23804.x (Pubitemid 40194675)
3. SJ Petty KD Hill NE Haber, et al. 2010 Balance impairment in chronic antiepileptic drug users: a twin and sibling study Epilepsia 51 2 280 288 19674052 10.1111/j.1528-1167.2009.02254.x 1:CAS:528:DC%2BC3cXisFerurg%3D This study identified impaired balance in persons with epilepsy using AEDs when compared with matched siblings not using AEDs. Balance impairment in persons with epilepsy may contribute to increased fracture risk. An assessment of balance should be considered in persons with epilepsy treated with AEDs.
4. P Vestergaard 2005 Epilepsy, osteoporosis and fracture risk-a meta-analysis Acta Neurol Scand 112 5 277 286 16218908 10.1111/j.1600-0404.2005. 00474.x 1:STN:280:DC%2BD2Mrkt12mtQ%3D%3D (Pubitemid 41530723)
5. AM Pack TS Walczak 2008 Bone health in women with epilepsy: clinical features and potential mechanisms Int Rev Neurobiol 83 305 328 18929090 10.1016/S0074-7742(08)00018-4
6. HB Persson KA Alberts BY Farahmand T Tomson 2002 Risk of extremity fractures in adult outpatients with epilepsy Epilepsia 43 7 768 772 12102682 10.1046/j.1528-1157.2002.15801.x (Pubitemid 34774261)
7. PC Souverein DJ Webb JG Weil TP Van Staa AC Egberts 2006 Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy Neurology 66 9 1318 1324 16682661 10.1212/01.wnl.0000210503.89488. 88 1:STN:280:DC%2BD283lvVeitw%3D%3D (Pubitemid 43739637)
8. I Tsiropoulos M Andersen T Nymark, et al. 2008 Exposure to antiepileptic drugs and the risk of hip fracture: a case-control study Epilepsia 49 12 2092 2099 18479399 10.1111/j.1528-1167.2008.01640.x
9. P Vestergaard L Rejnmark L Mosekilde 2004 Fracture risk associated with use of antiepileptic drugs Epilepsia 45 11 1330 1337 15509233 10.1111/j.0013-9580.2004.18804.x 1:CAS:528:DC%2BD2cXhtVGnsr3M (Pubitemid 39470036)
10. DL Andress J Ozuna D Tirschwell, et al. 2002 Antiepileptic drug-induced bone loss in young male patients who have seizures Arch Neurol 59 5 781 786 12020260 10.1001/archneur.59.5.781 (Pubitemid 34517760)
11. G Farhat B Yamout MA Mikati, et al. 2002 Effect of antiepileptic drugs on bone density in ambulatory patients Neurology 58 9 1348 1353 12011279 1:CAS:528:DC%2BD38Xktlyks74%3D (Pubitemid 34507160)
12. Y Sato I Kondo S Ishida, et al. 2001 Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy Neurology 57 3 445 449 11502911 1:CAS:528:DC%2BD3MXms1Srurw%3D (Pubitemid 32757591)
13. RD Sheth CA Wesolowski JC Jacob, et al. 1995 Effect of carbamazepine and valproate on bone mineral density J Pediatr 127 2 256 262 7636651 10.1016/S0022-3476(95)70304-7 1:CAS:528:DyaK2MXnsFGrsLs%3D
14. RD Sheth N Binkley BP Hermann 2008 Gender differences in bone mineral density in epilepsy Epilepsia 49 1 125 131 17683508 10.1111/j.1528-1167.2007. 01253.x
15. EA Samaniego RD Sheth 2007 Bone consequences of epilepsy and antiepileptic medications Semin Pediatr Neurol 14 4 196 200 18070676 10.1016/j.spen.2007.08.006 (Pubitemid 350216501)
16. G Coppola D Fortunato G Auricchio, et al. 2009 Bone mineral density in children, adolescents, and young adults with epilepsy Epilepsia 50 9 2140 2146 19486359 10.1111/j.1528-1167.2009.02082.x
17. RD Sheth N Binkley BP Hermann 2008 Progressive bone deficit in epilepsy Neurology 70 3 170 176 18057319 10.1212/01.wnl.0000284595.45880.93
18. RC Henderson RK Lark MJ Gurka, et al. 2002 Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy Pediatrics 110 1 Pt 1 e5 12093986 10.1542/peds.110.1.e5
19. B Menon CV Harinarayan 2010 The effect of anti epileptic drug therapy on serum 25-hydroxyvitamin D and parameters of calcium and bone metabolism-a longitudinal study Seizure 19 3 153 158 20144552 10.1016/j.seizure.2010.01.006
20. M Rauchenzauner A Griesmacher T Tatarczyk, et al. 2010 Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children Dev Med Child Neurol 52 3 283 288 19709134 10.1111/j.1469-8749.2009.03402.x
21. S Nettekoven A Ströhle B Trunz, et al. 2008 Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy Eur J Pediatr 167 12 1369 1377 18270736 10.1007/s00431-008-0672-7 1:CAS:528:DC%2BD1cXht1Grs7nN
22. Szulc P, Delmas PD. Biochemical markers of bone turnover in osteoporosis. In: Rosen CJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. New York: Lippincott Williams & Williams; 2009. p. 174-9.
23. AM Pack MJ Morrell A Randall DJ McMahon E Shane 2008 Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy Neurology 70 18 1586 1593 18443309 10.1212/01.wnl.0000310981.44676.de 1:CAS:528: DC%2BD1cXltVWntL8%3D (Pubitemid 351620313)
24. M Sowers M Crutchfield R Bandekar, et al. 1998 Bone mineral density and its change in pre- and perimenopausal white women: the Michigan Bone Health Study J Miner Res 13 7 1134 1140 10.1359/jbmr.1998.13.7.1134 1:STN:280:DyaK1czisFGiug%3D%3D (Pubitemid 28311781)
25. KE Ensrud TS Walczak T Blackwell ER Ensrud PJ Bowman KL Stone 2004 Antiepileptic drug use increases rates of bone loss in older women: a prospective study Neurology 62 11 2051 2057 15184613 1:CAS:528: DC%2BD2cXktVKgt7g%3D (Pubitemid 38738220)
26. A Verrotti R Greco G Morgese F Chiarelli 2000 Increased bone turnover in epileptic patients treated with carbamazepine Ann Neurol 47 3 385 388 10716262 10.1002/1531-8249(200003)47:3<385::AID-ANA18>3.0.CO;2-W 1:CAS:528:DC%2BD3cXitFaktbw%3D (Pubitemid 30141852)
27. A Verrotti R Greco G Latini G Morgese F Chiarelli 2002 Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine Epilepsia 43 12 1488 1492 12460249 10.1046/j.1528-1157.2002.13002. x 1:CAS:528:DC%2BD38XpslersLo%3D (Pubitemid 35429765)
28. SH Kim JW Lee KG Choi HW Chung HW Lee 2007 A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy Epilepsy and Behavior 10 2 291 295 17224308 10.1016/j.yebeh.2006.11.007 (Pubitemid 46432218)
29. S Mintzer P Boppana J Toguri, et al. 2006 Vitamin D levels and bone turnover in epilepsy taking carbamazepine or oxcarbazepine Epilepsia 47 3 510 515 16529614 10.1111/j.1528-1167.2006.00460.x 1:CAS:528:DC%2BD28XjslWgsr0%3D (Pubitemid 43351553)
30. A Cansu E Yesilkaya A Serdaroǧlu, et al. 2008 Evaluation of bone turnover in epileptic children using oxcarbazepine Pediatr Neurol 39 4 266 271 18805365 10.1016/j.pediatrneurol.2008.07.001
31. CY Gou GM Ronen SA Atkinson 2001 Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy Epilepsia 42 9 1141 1147 (Pubitemid 32947933)
32. A Verrotti S Agostinelli G Coppola P Parisi F Chiarelli 2010 A 12-month longitudinal study of calcium metabolism and bone turnover during valproate monotherapy Eur J Neurol 17 2 232 237 19682062 10.1111/j.1468-1331.2009.02773.x 1:STN:280:DC%2BC3czitleqtw%3D%3D
33. KE Ensrud TS Walczak TL Blackwell, et al. 2008 Antiepileptic drug use and rates of hip bone loss in older men: a prospective study Neurology 71 10 723 730 18765648 10.1212/01.wnl.0000324919.86696.a9 1:CAS:528:DC%2BD1cXhtVejtr7N This prospective study in older men found that treatment with non-enzyme-inducing AEDs (mostly gabapentin) was associated with bone loss at the hip. The indication for use was not identified, so it was not clear whether all subjects were treated with this agent for epilepsy or for other indications such as pain. This study highlights the need for further study of all available AEDs.
34. RD Sheth BP Hermann 2007 Bone mineral density with lamotrigine monotherapy for epilepsy Pediatr Neurol 37 4 250 254 17903668 10.1016/j.pediatrneurol.2007.05.018 (Pubitemid 47446154)
35. WM Pierce Jr GF Nardin MF Fuqua, et al. 1991 Effect of chronic carbonic anhydrase inhibitor therapy on bone and mineral density in white women J Bone Miner Res 6 4 347 354 1858521 10.1002/jbmr.5650060406
36. LS Nissen-Meyer S Svalheim E Tauboll, et al. 2007 Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism Epilepsia 48 10 1 11 10.1111/j.1528-1167.2007.01176.x (Pubitemid 47537449)
37. JM Pascussi A Robert M Nguyen, et al. 2005 Possible involvement of pregnane X receptor-enhanced CYP 24 expression in drug-induced osteomalacia J Clin Invest 115 1 177 186 15630458 1:CAS:528:DC%2BD2MXis1eqtA%3D%3D (Pubitemid 40385519)
38. C Zhou M Assem JC Tay, et al. 2006 Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia J Clin Invest 116 6 1703 1712 16691293 10.1172/JCI27793 1:CAS:528:DC%2BD28XlsFWqs7o%3D
39. AM Pack MJ Morrell R Marcus, et al. 2005 Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy Ann Neurol 57 2 781 786 10.1002/ana.20378 (Pubitemid 40179863)
40. LJ Stephen AR McLellan JH Harrison, et al. 1999 Bone density and antiepileptic drugs: a case-controlled study Seizure 8 6 339 342 10512774 10.1053/seiz.1999.0301 1:STN:280:DyaK1MvksVSntA%3D%3D (Pubitemid 29469322)
41. R Bhatt S Bhatt M Hameed P Rameshwar A Siegel 2006 Amygdaloid kindled seizures can induce functional and pathological changes in thymus of rat: role of the sympathetic nervous system Neurobiol Dis 21 1 127 137 16084731 10.1016/j.nbd.2005.06.018 1:CAS:528:DC%2BD2MXhtlCkt7nL (Pubitemid 41817313)
42. I Lambrinoudaki G Kaparos E Armeni, et al. 2011 BsmI vitamin D receptor's polymorphism and bone mineral density in men and premenopausal women on long-term antiepileptic therapy Eur J Neurol 18 1 93 98 20500803 10.1111/j.1468-1331.2010.03103.x 1:STN:280:DC%2BC3M%2Fislyjtw%3D%3D In this study of 73 persons with epilepsy who were long-term users of AEDs, vitamin D receptor polymorphism was associated with lower BMD. This novel study suggests that a genetic predisposition may influence whether a person with epilepsy treated with AEDs is at significant risk of bone loss.
43. AM Pack 2011 Genetic variation may clarify the relationship between epilepsy, antiepileptic drugs, and bone health Eur J Neurol. 18 1 3 4 20629722 10.1111/j.1468-1331.2010.03137.x 1:STN:280:DC%2BC3M%2FivVCgtA%3D%3D
44. A Thakkinstian C D'Este J Eisman T Nguyen J Attia 2004 Meta-analysis of molecular association studies: vitamin D receptor gene polymorphisms and BMD as a case study J Bone Miner Res. 19 419 428 15040830 10.1359/JBMR.0301265 1:CAS:528:DC%2BD2cXisFCrsb0%3D (Pubitemid 38787397)
45. FRAX®: WHO risk factor tool. Available at: http://www.sheffield.ac. uk/FRAX/. Accessed April 8, 2011.
46. MA Mikati L Dib B Yamout, et al. 2006 Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone Neurology 67 11 2005 2014 17159108 10.1212/01.wnl.0000247107.54562.0e 1:CAS:528:DC%2BD28Xht1Gmtb3E (Pubitemid 44967378)
47. IOM (Institute of Medicine). 2011. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press. Available at: http://www.iom.edu/vitamind. Accessed April 8, 2011.